Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa reivindicada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions consulte Mais informação
The great people I work with.
Quais são algumas das melhores coisas da sua equipe?
Most friendly welcoming team that I have worked with!
Qual é a coisa mais positiva da cultura e do ambiente da sua empresa?
Such a warm welcoming environment!
O que você mais gosta nos lideres?
Very teamwork oriented. The team strives to accomplish goals and milestones to better the company.
Other Employee Reviews for Karyopharm Therapeutics
×